10-Q Filing

SURGERY PARTNERS, INC. CIK: 1638833 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001638833-20-000058`
Period End Date	20200630
Filing Date	20200805
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	sgry-20200630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 94 Income Statement 126 Cash Flow Statement 74 Stockholders Equity 42 Comprehensive Income 22

Balance Sheet 94 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$110.70M	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$152.00M	USD	Point-in-time
Redeemable preferred stock, shares authorized (shares)	`TemporaryEquitySharesAuthorized`	310,000.00	shares	Point-in-time
Redeemable preferred stock, shares authorized (shares)	`TemporaryEquitySharesAuthorized`	310,000.00	shares	Point-in-time
Redeemable preferred stock, shares issued (shares)	`TemporaryEquitySharesIssued`	310,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$92.70M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$326.30M	USD	Point-in-time
Redeemable preferred stock, shares issued (shares)	`TemporaryEquitySharesIssued`	310,000.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$310.90M	USD	Point-in-time
Redeemable preferred stock, shares outstanding (shares)	`TemporaryEquitySharesOutstanding`	310,000.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$326.90M	USD	Point-in-time
Redeemable preferred stock, shares outstanding (shares)	`TemporaryEquitySharesOutstanding`	310,000.00	shares	Point-in-time
Inventories	`InventoryNet`	$49.00M	USD	Point-in-time
Redeemable preferred stock, redemption value	`RedeemableNoncontrollingInterestEquityPreferredRedemptionValue`	$395.00M	USD	Point-in-time
Redeemable preferred stock, redemption value	`RedeemableNoncontrollingInterestEquityPreferredRedemptionValue`	$414.20M	USD	Point-in-time
Inventories	`InventoryNet`	$46.30M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$23.30M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$17.80M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$37.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$41.80M	USD	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$746.50M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$525.50M	USD	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $152.0 and $110.7, respectively	`PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets`	$523.30M	USD	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $152.0 and $110.7, respectively	`PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets`	$504.30M	USD	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$3.45B	USD	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$3.45B	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$93.20M	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$91.10M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	50.55M	shares	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$311.70M	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$297.70M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	49.30M	shares	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	50.55M	shares	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$114.80M	USD	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$98.70M	USD	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	49.30M	shares	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$30.80M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$21.70M	USD	Point-in-time
Total assets	`Assets`	$5.24B	USD	Point-in-time
Total assets	`Assets`	$5.02B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$104.70M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$96.70M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$54.20M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$57.90M	USD	Point-in-time
Medicare accelerated payments and deferred governmental grants	`MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent`	$124.70M	USD	Point-in-time
Medicare accelerated payments and deferred governmental grants	`MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent`	-	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$220.40M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$191.20M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$56.00M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$63.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$571.20M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$398.10M	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.62B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.52B	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$283.10M	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$298.90M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$127.30M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$113.60M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$326.60M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$316.00M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$321.00M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$314.70M	USD	Point-in-time
Redeemable preferred stock - Series A; shares authorized, issued and outstanding - 310,000; redemption value - $414.2 and $395.0, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$395.00M	USD	Point-in-time
Redeemable preferred stock - Series A; shares authorized, issued and outstanding - 310,000; redemption value - $414.2 and $395.0, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$414.20M	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 50,551,483 and 49,298,940, respectively	`CommonStockValueOutstanding`	$500.00K	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 50,551,483 and 49,298,940, respectively	`CommonStockValueOutstanding`	$500.00K	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$296.80M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$204.40M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$686.60M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$691.50M	USD	Point-in-time
Other stockholders' equity	`OtherStockholdersEquityAttributableToParent`	$203.90M	USD	Point-in-time
Other stockholders' equity	`OtherStockholdersEquityAttributableToParent`	$296.30M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$923.40M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.04B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$983.40M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.10B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$895.90M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$5.24B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$5.02B	USD	Point-in-time

Income Statement 126 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$815.70M	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$445.40M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$374.70M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$862.20M	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$261.90M	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$256.50M	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$132.70M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$116.10M	USD	1 Quarter
Supplies	`SuppliesExpense`	$238.40M	USD	2 Qtrs
Supplies	`SuppliesExpense`	$239.40M	USD	2 Qtrs
Supplies	`SuppliesExpense`	$123.40M	USD	1 Quarter
Supplies	`SuppliesExpense`	$110.10M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$71.50M	USD	2 Qtrs
Professional and medical fees	`ProfessionalFees`	$36.40M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$45.30M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$92.10M	USD	2 Qtrs
Lease expense	`OperatingAndFinanceLeaseExpense`	$21.00M	USD	1 Quarter
Lease expense	`OperatingAndFinanceLeaseExpense`	$41.60M	USD	2 Qtrs
Lease expense	`OperatingAndFinanceLeaseExpense`	$42.80M	USD	2 Qtrs
Lease expense	`OperatingAndFinanceLeaseExpense`	$21.50M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$26.30M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$26.90M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$53.10M	USD	2 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$54.70M	USD	2 Qtrs
Cost of revenues	`OperatingCostsAndExpenses`	$319.30M	USD	1 Quarter
Cost of revenues	`OperatingCostsAndExpenses`	$685.50M	USD	2 Qtrs
Cost of revenues	`OperatingCostsAndExpenses`	$666.50M	USD	2 Qtrs
Cost of revenues	`OperatingCostsAndExpenses`	$340.40M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$45.00M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$48.10M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$25.30M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$23.30M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$23.40M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$19.10M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$45.20M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$37.90M	USD	2 Qtrs
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$2.50M	USD	1 Quarter
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$4.20M	USD	2 Qtrs
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$4.50M	USD	2 Qtrs
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$2.20M	USD	1 Quarter
Loss (gain) on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-2.90M	USD	1 Quarter
Loss (gain) on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-6.40M	USD	2 Qtrs
Loss (gain) on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$7.60M	USD	2 Qtrs
Loss (gain) on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$8.20M	USD	1 Quarter
Grant funds	`GrantRevenue`	$43.10M	USD	1 Quarter
Grant funds	`GrantRevenue`	-	USD	2 Qtrs
Grant funds	`GrantRevenue`	$43.10M	USD	2 Qtrs
Grant funds	`GrantRevenue`	-	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$4.90M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$8.20M	USD	2 Qtrs
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$10.40M	USD	2 Qtrs
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$6.20M	USD	1 Quarter
Litigation settlement	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Litigation settlement	`GainLossRelatedToLitigationSettlement`	$-46.00M	USD	Annual
Litigation settlement	`GainLossRelatedToLitigationSettlement`	$-1.20M	USD	2 Qtrs
Litigation settlement	`GainLossRelatedToLitigationSettlement`	-	USD	2 Qtrs
Litigation settlement	`GainLossRelatedToLitigationSettlement`	$1.20M	USD	1 Quarter
Litigation settlement	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-11.70M	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-11.70M	USD	1 Quarter
Other income	`OtherNonrecurringIncomeExpense`	$-200.00K	USD	1 Quarter
Other income	`OtherNonrecurringIncomeExpense`	$-1.70M	USD	2 Qtrs
Other income	`OtherNonrecurringIncomeExpense`	$-400.00K	USD	2 Qtrs
Other income	`OtherNonrecurringIncomeExpense`	$-400.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$330.00M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$747.50M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$757.10M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$389.90M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$44.70M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$55.50M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$68.20M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$105.10M	USD	2 Qtrs
Tax receivable agreement expense	`TaxReceivableAgreementExpenseBenefit`	-	USD	2 Qtrs
Tax receivable agreement expense	`TaxReceivableAgreementExpenseBenefit`	$2.40M	USD	2 Qtrs
Tax receivable agreement expense	`TaxReceivableAgreementExpenseBenefit`	-	USD	1 Quarter
Tax receivable agreement expense	`TaxReceivableAgreementExpenseBenefit`	-	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-88.40M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-49.20M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-96.30M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-46.40M	USD	1 Quarter
(Loss) income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$9.10M	USD	1 Quarter
(Loss) income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$14.30M	USD	2 Qtrs
(Loss) income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-28.10M	USD	2 Qtrs
(Loss) income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-4.50M	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-15.80M	USD	2 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-600.00K	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$2.70M	USD	2 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$1.00M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-12.30M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$-3.90M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$11.60M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$8.10M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$27.90M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$51.50M	USD	2 Qtrs
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$28.60M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$47.70M	USD	2 Qtrs
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-60.00M	USD	2 Qtrs
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-32.50M	USD	1 Quarter
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-39.90M	USD	2 Qtrs
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-19.80M	USD	1 Quarter
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$9.70M	USD	1 Quarter
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$19.20M	USD	2 Qtrs
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$17.30M	USD	2 Qtrs
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$8.80M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-79.20M	USD	2 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-57.20M	USD	2 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-42.20M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-28.60M	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.86	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-1.63	USD	2 Qtrs
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.59	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-1.19	USD	2 Qtrs
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-1.63	USD	2 Qtrs
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.59	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.86	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-1.19	USD	2 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.29M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.84M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.66M	shares	2 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.24M	shares	2 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.84M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.24M	shares	2 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.66M	shares	2 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.29M	shares	1 Quarter

Cash Flow Statement 74 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`ProfitLoss`	$-12.30M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$-3.90M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$11.60M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$8.10M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$23.40M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$19.10M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$45.20M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$37.90M	USD	2 Qtrs
Non-cash interest expense (income), net	`NoncashInterestIncomeExpenseNet`	$-2.20M	USD	2 Qtrs
Non-cash interest expense (income), net	`NoncashInterestIncomeExpenseNet`	$-100.00K	USD	2 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$3.00M	USD	1 Quarter
Equity-based compensation expense	`ShareBasedCompensation`	$3.40M	USD	1 Quarter
Equity-based compensation expense	`ShareBasedCompensation`	$6.90M	USD	2 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$4.90M	USD	2 Qtrs
Loss (gain) on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-2.90M	USD	1 Quarter
Loss (gain) on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-6.40M	USD	2 Qtrs
Loss (gain) on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$7.60M	USD	2 Qtrs
Loss (gain) on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$8.20M	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-11.70M	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-11.70M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$2.00M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-16.40M	USD	2 Qtrs
(Loss) income from equity investments, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$200.00K	USD	2 Qtrs
(Loss) income from equity investments, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$-100.00K	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseExpense`	$20.10M	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseExpense`	$19.60M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-16.30M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-6.90M	USD	2 Qtrs
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$124.70M	USD	2 Qtrs
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	-	USD	2 Qtrs
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-18.20M	USD	2 Qtrs
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$40.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$211.10M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$47.20M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$31.80M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$19.90M	USD	2 Qtrs
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$13.20M	USD	2 Qtrs
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$12.40M	USD	2 Qtrs
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	$17.60M	USD	2 Qtrs
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	$9.40M	USD	2 Qtrs
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$15.20M	USD	2 Qtrs
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	-	USD	2 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$-400.00K	USD	2 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$300.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-22.50M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-42.90M	USD	2 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$182.80M	USD	2 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$422.80M	USD	2 Qtrs
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$438.90M	USD	2 Qtrs
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$288.20M	USD	2 Qtrs
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$6.50M	USD	2 Qtrs
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$8.80M	USD	2 Qtrs
Payment of premium on debt extinguishment	`DebtInstrumentPrepaymentPenaltyAmount`	-	USD	2 Qtrs
Payment of premium on debt extinguishment	`DebtInstrumentPrepaymentPenaltyAmount`	$17.80M	USD	2 Qtrs
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$60.90M	USD	2 Qtrs
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$51.70M	USD	2 Qtrs
(Payments) receipts related to ownership transactions with non-controlling interest holders	`ProceedsFromPaymentsToMinorityShareholders`	$1.20M	USD	2 Qtrs
(Payments) receipts related to ownership transactions with non-controlling interest holders	`ProceedsFromPaymentsToMinorityShareholders`	$-1.90M	USD	2 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-300.00K	USD	2 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-1.00M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-71.20M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$45.00M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-66.90M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$233.60M	USD	2 Qtrs
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$326.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$184.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$93.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$117.70M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$326.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$184.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$93.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$117.70M	USD	Point-in-time

Stockholders Equity 42 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	50.55M	shares	Point-in-time
Beginning Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	49.30M	shares	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$923.40M	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.04B	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$983.40M	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.10B	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$895.90M	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-4.10M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-9.70M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-13.90M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-1.10M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$900.00K	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.10M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.80M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.80M	USD	1 Quarter
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$8.50M	USD	1 Quarter
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$9.50M	USD	1 Quarter
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$8.80M	USD	1 Quarter
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$9.70M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$7.30M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-17.90M	USD	2 Qtrs
Other comprehensive loss	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-25.20M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-11.50M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-16.80M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-28.30M	USD	2 Qtrs
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$14.10M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$1.70M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$700.00K	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$2.00M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$23.50M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$20.90M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$14.90M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$17.70M	USD	1 Quarter
Ending Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	50.55M	shares	Point-in-time
Ending Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	49.30M	shares	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$923.40M	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.04B	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$983.40M	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.10B	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$895.90M	USD	Point-in-time

Comprehensive Income 22 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`ProfitLoss`	$-12.30M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$-3.90M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$11.60M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$8.10M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$7.30M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-17.90M	USD	2 Qtrs
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-25.20M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-11.50M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-16.80M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-28.30M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-30.20M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.40M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-8.70M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-16.70M	USD	2 Qtrs
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$51.50M	USD	2 Qtrs
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$47.70M	USD	2 Qtrs
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$27.90M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$28.60M	USD	1 Quarter
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-36.60M	USD	1 Quarter
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-77.90M	USD	2 Qtrs
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-25.20M	USD	1 Quarter
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-68.20M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.